Evidence that the reward attenuating effect of the D1-like antagonist, SCH-23390, is not mediated by its agonist action at the 5-HT2c receptors

被引：5
|
作者：
Benaliouad, Faiza [1 ]
Zhornitsky, Simon [2 ]
Rompre, Pierre-Paul [2 ,3 ]
机构：
[1] Univ Montreal, Dept Physiol, Montreal, PQ H1N 3V2, Canada
[2] Univ Montreal, Dept Psychiat, Montreal, PQ H1N 3V2, Canada
[3] Concordia Univ, FRSQ Res Grp Behav Neurobiol, Montreal, PQ H4B 1R6, Canada
来源：
BEHAVIOURAL BRAIN RESEARCH | 2011年 / 217卷 / 02期
关键词：
Dopamine; Reward; Serotonin; SB-242,084; SCH-23390; SELF-STIMULATION THRESHOLDS; VENTRAL TEGMENTAL AREA; BRAIN-STIMULATION; NUCLEUS-ACCUMBENS; IN-VIVO; SEROTONIN(2C) RECEPTORS; CONSTITUTIVE ACTIVITY; DOPAMINE; DRUGS; BLOCKADE;
D O I：
10.1016/j.bbr.2010.09.023
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
This study investigated the effect of the 5-HT2c receptor antagonist, SB-242,084, on the attenuation of brain stimulation reward by SCH-23390. An additional experiment determined the effectiveness of SB-242,084 at blocking the reward attenuating effect of 5-HT2c agonist, CP-809,101. Results show that SB-242,084 blocked the reward attenuating effect of CP-809,101 but failed to alter that of SCH-23390. These findings provide evidence that the agonist action of SCH-23390 at the 5-HT2c receptors does not contribute to its attenuating effect on reward. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码：467 / 471
页数：5
相关论文
共 50 条
  • [1] THE BINDING OF SCH-39166 AND SCH-23390 TO 5-HT1C RECEPTORS IN PORCINE CHOROID-PLEXUS
    TAYLOR, LA
    TEDFORD, CE
    MCQUADE, RD
    [J]. LIFE SCIENCES, 1991, 49 (20) : 1505 - 1511
  • [2] HYPOPHAGIC EFFECT OF FLUOXETINE IN RATS IS NOT MEDIATED BY INHIBITION OF 5-HT REUPTAKE OR AN AGONIST ACTION AT 5-HT2C RECEPTORS
    LIGHTOWLER, S
    KENNETT, GA
    WOOD, MD
    BROWN, AM
    GLEN, A
    BLACKBURN, TP
    TULLOCH, IF
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U157 - U157
  • [3] Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH-23390 or the serotonin 5-HT2C agonist lorcaserin
    DiPalma, Devon
    Rezvani, Amir H.
    Willette, Blair
    Wells, Corinne
    Slade, Susan
    Hall, Brandon J.
    Levin, Edward D.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2019, 176 : 16 - 22
  • [4] Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment
    Jarmo Hietala
    Mikko Kuoppamäki
    Hannu Majasuo
    Esa-Pekka Pälvimäki
    Aki Laakso
    Erkka Syvälahti
    [J]. Psychopharmacology, 2001, 157 : 180 - 187
  • [5] Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist but not antagonist binding to 5-HT2c receptors after chronic treatment
    Hietala, J
    Kuoppamäki, M
    Majasuo, H
    Pälvimäki, EP
    Laakso, A
    Syvälahti, E
    [J]. PSYCHOPHARMACOLOGY, 2001, 157 (02) : 180 - 187
  • [6] SCH-23390 - A SELECTIVE DOPAMINE D-1 RECEPTOR ANTAGONIST WITH PUTATIVE 5-HT1 RECEPTOR AGONISTIC ACTIVITY
    SKARSFELDT, T
    LARSEN, JJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 148 (03) : 389 - 395
  • [7] ATTENUATION OF THE LOCOMOTOR-SENSITIZING EFFECTS OF THE D-2 DOPAMINE AGONIST BROMOCRIPTINE BY EITHER THE D-1 ANTAGONIST SCH-23390 OR THE D-2 ANTAGONIST RACLOPRIDE
    WISE, RA
    CARLEZON, WA
    [J]. SYNAPSE, 1994, 17 (03) : 155 - 159
  • [8] INTERACTION OF SCH-23390, A D-1-SELECTIVE ANTAGONIST, WITH THE ANTERIOR-PITUITARY D-2 RECEPTORS AND PROLACTIN SECRETION IN THE RAT
    APUD, JA
    MASOTTO, C
    ONGINI, E
    RACAGNI, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 112 (02) : 187 - 193
  • [9] The melatonergic agonist and clinically active antidepressant, agomelatine, is a neutral antagonist at 5-HT2C receptors
    Millan, Mark J.
    Marin, Philippe
    Kamal, Maud
    Jockers, Ralf
    Chanrion, Benjamin
    Labasque, Marilyne
    Bockaert, Joel
    la Cour, Clotilde Mannoury
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2011, 14 (06): : 768 - 783
  • [10] Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats
    Ferreira, HS
    Oliveira, E
    Faustino, TN
    Silva, EDE
    Fregoneze, JB
    [J]. BRAIN RESEARCH, 2005, 1040 (1-2) : 64 - 72
12345